![Kenneth Graabek Johansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth Graabek Johansen
Finanzdirektor/CFO bei 2CUREX AB
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Ole Thastrup | M | 71 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 18 Jahre |
Grith Hagel | F | 65 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 18 Jahre |
Povl-André Bang Bendz | M | 62 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 10 Jahre |
Michael Lutz | M | 56 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 4 Jahre |
Michael Schaefer | M | - |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 2 Jahre |
Camilla Huse Bondesson | M | 66 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 5 Jahre |
Fernando Andreu | M | 60 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 3 Jahre |
Tabea Sturmheti | M | 39 | 7 Jahre | |
Raphael Gruber | M | 60 | 2 Jahre | |
Jesper Kristiansen | M | 59 | 3 Jahre | |
Manuel Fernández | M | - | 2 Jahre | |
Jørgen Drejer | M | 69 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 7 Jahre |
Mark Gray | M | 54 | 2 Jahre | |
Ulrich Karl Walter Spengler | M | 57 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 11 Jahre |
Simon Hesse Hoffmann | M | 46 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 7 Jahre |
Nils Aage Brünner | M | 72 |
2cureX ApS
![]() 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 4 Jahre |
Tonni Bülow-Nielsen | M | - | 1 Jahre | |
Jacob Thastrup | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michel Klimkeit | M | - | 1 Jahre | |
Maarten van der Linden | M | 55 | 4 Jahre | |
Carit Jacques Andersen | M | 60 | 2 Jahre | |
Henrik Harling | M | 71 | 3 Jahre | |
Pia van der Zee | F | - | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweden | 19 | 82,61% |
Dänemark | 11 | 47,83% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kenneth Graabek Johansen
- Persönliches Netzwerk